[HTML][HTML] Prognostic implications of ezrin and phosphorylated ezrin expression in non-small cell lung cancer
T Jin, J Jin, X Li, S Zhang, YH Choi, Y Piao, X Shen… - BMC cancer, 2014 - Springer
Background The cytoskeletal organizer ezrin is a member of the ezrin-radixin-moesin (ERM)
family and plays important roles in not only cell motility, cell adhesion, and apoptosis, but …
family and plays important roles in not only cell motility, cell adhesion, and apoptosis, but …
[HTML][HTML] The effect of ShenQi FuZheng injection in combination with chemotherapy versus chemotherapy alone on the improvement of efficacy and immune function in …
C Dedong, X Huilin, H Anbing, X Ximing, G Wei - PLoS one, 2016 - journals.plos.org
Objective To evaluate the effect of ShenQi FuZheng Injection (SFI) on cellular immunity and
clinical efficacy in patients with advanced non small cell lung cancer (NSCLC) when …
clinical efficacy in patients with advanced non small cell lung cancer (NSCLC) when …
[HTML][HTML] Icotinib is an active treatment of non-small-cell lung cancer: a retrospective study
X Chen, Q Zhu, Y Liu, P Liu, Y Yin, R Guo, K Lu, Y Gu… - PloS one, 2014 - journals.plos.org
Background Icotinib hydrochloride is a novel epidermal growth factor receptor (EGFR)
tyrosine kinase inhibitor (TKI) with preclinical and clinical activity in non-small cell lung …
tyrosine kinase inhibitor (TKI) with preclinical and clinical activity in non-small cell lung …
High cofilin-1 levels correlate with cisplatin resistance in lung adenocarcinomas
M Becker, MA De Bastiani, CB Müller, MM Markoski… - Tumor Biology, 2014 - Springer
High cofilin-1 levels have been shown to be an accurate prognostic biomarker in non-small
cell lung cancer (NSCLC) and a predictive factor in drug resistance. Herein we explore the …
cell lung cancer (NSCLC) and a predictive factor in drug resistance. Herein we explore the …
Presence of pleural effusion is associated with a poor prognosis in patients with epidermal growth factor receptor–mutated lung cancer receiving tyrosine kinase …
Aim This study was conducted to evaluate the effect of clinical factors on the treatment
outcomes of lung cancer patients with active epidermal growth factor receptor (EGFR) …
outcomes of lung cancer patients with active epidermal growth factor receptor (EGFR) …
[HTML][HTML] Epidermal growth factor receptor mutation in non-small-cell lung carcinomas: A retrospective analysis of 1036 lung cancer specimens from a network of …
VH Veldore, RM Rao, S Kakara… - Indian Journal of …, 2013 - journals.lww.com
BACKGROUND: Epidermal growth factor receptor (EGFR) mutation plays a vital role in the
prognosis of patients with lung cancer. However, there is a dearth of studies on EGFR …
prognosis of patients with lung cancer. However, there is a dearth of studies on EGFR …
The efficacy and safety of EGFR inhibitor monotherapy in non-small cell lung cancer: a systematic review
XW Yang, K Yang, KY Kuang - Current oncology reports, 2014 - Springer
Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) have been
extensively investigated in previously treated advanced non-small-cell lung cancer …
extensively investigated in previously treated advanced non-small-cell lung cancer …
[HTML][HTML] A prognostic model for predicting progression-free survival in patients with advanced non-small cell lung cancer after image-guided microwave ablation plus …
F Kong, H Yang, Q Wang, Z Wei, X Ye - European radiology, 2023 - Springer
Objectives This study aimed to build and validate a prediction model that can predict
progression-free survival (PFS) in patients with advanced non-small cell lung cancer …
progression-free survival (PFS) in patients with advanced non-small cell lung cancer …
[HTML][HTML] Hidden treasures in “ancient” microarrays: gene-expression portrays biology and potential resistance pathways of major lung cancer subtypes and normal …
K Kerkentzes, V Lagani, I Tsamardinos… - Frontiers in …, 2014 - frontiersin.org
Objective: Novel statistical methods and increasingly more accurate gene annotations can
transform “old” biological data into a renewed source of knowledge with potential clinical …
transform “old” biological data into a renewed source of knowledge with potential clinical …
Epidermal growth factor receptor‐tyrosine kinase inhibitors in advanced squamous cell carcinoma of the lung: A meta‐analysis
M Ameratunga, N Pavlakis, V Gebski… - Asia‐Pacific Journal …, 2014 - Wiley Online Library
Aim Tyrosine kinase inhibitors (TKI s) targeting the epidermal growth factor receptor (EGFR)
are well established in treating metastatic pulmonary adenocarcinoma, especially patients …
are well established in treating metastatic pulmonary adenocarcinoma, especially patients …